References
- Tan ST, Kwan AT, Rodriguez-Barraquer I, Singer BJ, Park HJ, Lewnard JA, Sears D, Lo NC. Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave. MedRxiv [ preprint]. 2022. doi:10.1101/2022.08.08.22278547.
- Palmer CD, Rappaport AR, Davis MJ, Hart MG, Scallan CD, Hong SJ, Gitlin L, Kraemer LD, Kounlavouth S, Yang A, et al. Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results. Nat Med. 2022;28(8):1–2. doi:10.1038/s41591-022-01937-6.
- Chen N, Pu C, Zhao L, Wang C, Zhu R, Liang T, Huang X, Tang H, Wang Y, Jia B, et al. Dose escalation study of GCC19CART CoupledCAR ® technology for patients with relapsed or refractory colorectal cancer. Blood. 2021;138(Supplement 1):4841. doi:10.1182/blood-2021-153429.